Phase III, Randomized, Double Blind Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients.
Phase of Trial: Phase III
Latest Information Update: 20 Apr 2012
At a glance
- Drugs Colecalciferol (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Acronyms MelaViD
- 02 Aug 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 02 Aug 2011 Actual initiation date change from Dec 2010 to May 2010 as reported by ClinicalTrials.gov.
- 25 Dec 2010 New trial record